These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

856 related articles for article (PubMed ID: 20113459)

  • 1. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients.
    Neofytos D; Fishman JA; Horn D; Anaissie E; Chang CH; Olyaei A; Pfaller M; Steinbach WJ; Webster KM; Marr KA
    Transpl Infect Dis; 2010 Jun; 12(3):220-9. PubMed ID: 20113459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
    Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K
    Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).
    Pappas PG; Alexander BD; Andes DR; Hadley S; Kauffman CA; Freifeld A; Anaissie EJ; Brumble LM; Herwaldt L; Ito J; Kontoyiannis DP; Lyon GM; Marr KA; Morrison VA; Park BJ; Patterson TF; Perl TM; Oster RA; Schuster MG; Walker R; Walsh TJ; Wannemuehler KA; Chiller TM
    Clin Infect Dis; 2010 Apr; 50(8):1101-11. PubMed ID: 20218876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne.
    Pagano L; Caira M; Nosari A; Van Lint MT; Candoni A; Offidani M; Aloisi T; Irrera G; Bonini A; Picardi M; Caramatti C; Invernizzi R; Mattei D; Melillo L; de Waure C; Reddiconto G; Fianchi L; Valentini CG; Girmenia C; Leone G; Aversa F
    Clin Infect Dis; 2007 Nov; 45(9):1161-70. PubMed ID: 17918077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi.
    Husain S; Alexander BD; Munoz P; Avery RK; Houston S; Pruett T; Jacobs R; Dominguez EA; Tollemar JG; Baumgarten K; Yu CM; Wagener MM; Linden P; Kusne S; Singh N
    Clin Infect Dis; 2003 Jul; 37(2):221-9. PubMed ID: 12856215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database.
    Kontoyiannis DP; Marr KA; Park BJ; Alexander BD; Anaissie EJ; Walsh TJ; Ito J; Andes DR; Baddley JW; Brown JM; Brumble LM; Freifeld AG; Hadley S; Herwaldt LA; Kauffman CA; Knapp K; Lyon GM; Morrison VA; Papanicolaou G; Patterson TF; Perl TM; Schuster MG; Walker R; Wannemuehler KA; Wingard JR; Chiller TM; Pappas PG
    Clin Infect Dis; 2010 Apr; 50(8):1091-100. PubMed ID: 20218877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posaconazole as salvage therapy in patients with invasive fungal infections after solid organ transplant.
    Alexander BD; Perfect JR; Daly JS; Restrepo A; Tobón AM; Patino H; Hardalo CJ; Graybill JR
    Transplantation; 2008 Sep; 86(6):791-6. PubMed ID: 18813103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective screening in liver transplant recipients by panfungal PCR-ELISA for early diagnosis of invasive fungal infections.
    Badiee P; Kordbacheh P; Alborzi A; Malekhoseini S; Zeini F; Mirhendi H; Mahmoodi M
    Liver Transpl; 2007 Jul; 13(7):1011-6. PubMed ID: 17600362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors, clinical characteristics, and outcomes of invasive fungal infections in solid organ transplant recipients.
    Bodro M; Sabé N; Gomila A; Ayats J; Baliellas C; Roca J; Melilli E; Carratalà J
    Transplant Proc; 2012 Nov; 44(9):2682-5. PubMed ID: 23146493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in invasive disease due to Candida species following heart and lung transplantation.
    Schaenman JM; Rosso F; Austin JM; Baron EJ; Gamberg P; Miller J; Oyer PE; Robbins RC; Montoya JG
    Transpl Infect Dis; 2009 Apr; 11(2):112-21. PubMed ID: 19254327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylaxis, pre-emptive or empirical antifungal therapy: which is best in non-lung transplant recipients?
    Salavert M
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S149-53. PubMed ID: 19013340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicentre pharmacoepidemiological study of therapeutic practices in invasive fungal infections in France during 1998-1999.
    Lortholary O; Charlemagne A; Bastides F; Chevalier P; Datry A; Gonzalves MF; Michel G; Tilleul P; Veber B; Herbrecht R
    J Antimicrob Chemother; 2004 Aug; 54(2):456-64. PubMed ID: 15231769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central nervous system involvement in cryptococcal infection in individuals after solid organ transplantation or with AIDS.
    Davis JA; Horn DL; Marr KA; Fishman JA
    Transpl Infect Dis; 2009 Oct; 11(5):432-7. PubMed ID: 19638005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: an autopsy-driven survey.
    Sinkó J; Csomor J; Nikolova R; Lueff S; Kriván G; Reményi P; Bátai A; Masszi T
    Transpl Infect Dis; 2008 Apr; 10(2):106-9. PubMed ID: 17605727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presentation of the PATH Alliance registry for prospective data collection and analysis of the epidemiology, therapy, and outcomes of invasive fungal infections.
    Horn DL; Fishman JA; Steinbach WJ; Anaissie EJ; Marr KA; Olyaei AJ; Pfaller MA; Weiss MA; Webster KM; Neofytos D
    Diagn Microbiol Infect Dis; 2007 Dec; 59(4):407-14. PubMed ID: 17888614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT.
    Blennow O; Remberger M; Klingspor L; Omazic B; Fransson K; Ljungman P; Mattsson J; Ringdén O
    Bone Marrow Transplant; 2010 Dec; 45(12):1710-8. PubMed ID: 20190840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrum and risk factors for invasive candidiasis and non-Candida fungal infections after liver transplantation.
    Shi SH; Lu AW; Shen Y; Jia CK; Wang WL; Xie HY; Zhang M; Liang TB; Zheng SS
    Chin Med J (Engl); 2008 Apr; 121(7):625-30. PubMed ID: 18466683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of mycoses in surgical patients -- review of the literature.
    Holzheimer RG; Dralle H
    Eur J Med Res; 2002 May; 7(5):200-26. PubMed ID: 12069912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fungal infections in solid organ transplantation.
    Silveira FP; Husain S
    Med Mycol; 2007 Jun; 45(4):305-20. PubMed ID: 17510855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-transplant colonization with non-Aspergillus molds and risk of development of invasive fungal disease in lung transplant recipients.
    Silveira FP; Kwak EJ; Paterson DL; Pilewski JM; McCurry KR; Husain S
    J Heart Lung Transplant; 2008 Aug; 27(8):850-5. PubMed ID: 18656797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.